Other adverse effects also tended to be more frequent in patients with relapses, but differences did not reach statistical significance.
← all excerpts
Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients.
1
—
—